These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 9288793

  • 1. Paclitaxel- and docetaxel-dependent activation of CA-125 expression in human ovarian carcinoma cells.
    Marth C, Zeimet AG, Widschwendter M, Ludescher C, Kaern J, Tropé C, Gastl G, Daxenbichler G, Dapunt O.
    Cancer Res; 1997 Sep 01; 57(17):3818-22. PubMed ID: 9288793
    [Abstract] [Full Text] [Related]

  • 2. Taxane sensitivity of ovarian carcinoma in vitro.
    Engblom P, Rantanen V, Kulmala J, Heiskanen J, Grenman S.
    Anticancer Res; 1997 Sep 01; 17(4A):2475-9. PubMed ID: 9252666
    [Abstract] [Full Text] [Related]

  • 3. Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients.
    Sonnemann J, Gänge J, Pilz S, Stötzer C, Ohlinger R, Belau A, Lorenz G, Beck JF.
    BMC Cancer; 2006 Jul 11; 6():183. PubMed ID: 16834771
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effects of combining docetaxel and cyclooxygenase-2 inhibitors on proliferation and apoptosis in epithelial ovarian cancer.
    Munkarah AR, Ali-Fehmi R, Jiang JZ, Elhammady E, Malone JM, Saed GM.
    Anticancer Drugs; 2007 Sep 11; 18(8):889-96. PubMed ID: 17667594
    [Abstract] [Full Text] [Related]

  • 13. Paclitaxel-induced apoptosis is associated with expression and activation of c-Mos gene product in human ovarian carcinoma SKOV3 cells.
    Ling YH, Yang Y, Tornos C, Singh B, Perez-Soler R.
    Cancer Res; 1998 Aug 15; 58(16):3633-40. PubMed ID: 9721872
    [Abstract] [Full Text] [Related]

  • 14. In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumour and normal bone marrow cells.
    Braakhuis BJ, Hill BT, Dietel M, Kelland LR, Aapro MS, Zoli W, Lelieveld P.
    Anticancer Res; 1994 Aug 15; 14(1A):205-8. PubMed ID: 7909419
    [Abstract] [Full Text] [Related]

  • 15. A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenografts.
    Polizzi D, Pratesi G, Tortoreto M, Supino R, Riva A, Bombardelli E, Zunino F.
    Cancer Res; 1999 Mar 01; 59(5):1036-40. PubMed ID: 10070960
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Molecular description of evolving paclitaxel resistance in the SKOV-3 human ovarian carcinoma cell line.
    Lamendola DE, Duan Z, Yusuf RZ, Seiden MV.
    Cancer Res; 2003 May 01; 63(9):2200-5. PubMed ID: 12727840
    [Abstract] [Full Text] [Related]

  • 19. Anti-tumour activity of a panel of taxanes toward a cellular model of human cervical cancer.
    Gallo D, Ferlini C, Distefano M, Cantelmo F, Gaggini C, Fattorossi A, Riva A, Bombardelli E, Proietti E, Mancuso S, Scambia G.
    Cancer Chemother Pharmacol; 2000 May 01; 45(2):127-32. PubMed ID: 10663627
    [Abstract] [Full Text] [Related]

  • 20. Modulation of ovarian carcinoma tumor marker CA-125 by gamma-interferon.
    Marth C, Fuith LC, Böck G, Daxenbichler G, Dapunt O.
    Cancer Res; 1989 Dec 01; 49(23):6538-42. PubMed ID: 2510928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.